Opioid Drugs Market By Drug Type (Opioid Agonist (Morphine, Methadone, Codeine, Oxycodone, Meperidine, Fentanyl and Other Agonist), Opioid Antagonist (Naloxone, Naltrexone and Other Antagonist), By Application Type (Pain Management, Cough Suppressant, Diarrhea and Anesthesia)) - Growth, Future Prospects and Competitive Analysis, 2017 - 2025
Opioid is a drug class including a broad range of drugs such as morphine, oxycodone, fentanyl, hydrocodone and others with widened applications in pain management. Opioid drugs produce effective results by interacting with opioid receptors present on nerve cells. Globally, millions of people have been suffering from acute or chronic pain, thus having a huge impact on domestic healthcare expenditure and supporting the growth opportunity of opioid drugs market. Significant risk is associated with misuse of opioid drugs; therefore it is recommended to take these drugs with proper dose and in appropriate condition, with physician’s prescription.
Global sales of opioid drugs are greatly influenced by epidemiological factors such as high prevalence of cancer and chronic disorder. Opioid drugs market is also being driven by growing elderly-population, who are at high risk to suffer from mild to moderate pain. Trend towards purchasing over-the-counter opioid drugs and surging demand for recreational drugs are predicted to boost the growth of opioid drugs market. Deaths caused from opioid overdose have been escalating in recent years which is an epidemic in the United States. As per the record of the Centers for Disease Control and Prevention (CDC), opioid caused death of more than 33,000 people in the year 2015 and more than half of them caused due to prescribed opioids.
The sharp increasing trend of opioid overdose and addiction have arisen global health concern and hence many initiatives have been taken by governments and healthcare organizations exerting challenge to the growth of opioid drugs market. Market penetrance of non-opioid drugs to circumvent side-effects and risk associated with opioid drugs also hinder the growth opportunity of opioid drugs market.
The global opioid drugs market has been segmented on the basis of drugs type and application type. Opioid drugs are classified into morphine, methadone, codeine, oxycodone, meperidine, fentanyl and others; whereas as per application, the market is categorized into pain management, cough suppressant, anesthesia and diarrhea. This report is comprised of the cross-sectional details of every segment and sub-segment containing data for the base year of 2016 and projected to 2025 with corresponding CAGR calculated from 2017-2025.
The report on global opioid drugs market offers detailed market insights and comprehensive analysis of market dynamics comprising market drivers, restrains and opportunity with future prospects of opioid drugs market to allow industry experts to identify business opportunities and valuable information about prevailing trend of market to take business decision. Competitive landscape analysis of manufacturers with mergers and acquisition activities, major partnerships, collaboration, have been delivered in the study to develop accurate business strategies.
The opioid drugs market is segmented into five main regions, which are further sub-segmented as follows:
- North America
- The United States
- Canada
- Europe
- The United Kingdom
- Germany
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- Gulf Cooperation Council (GCC)
- Rest of Middle East and Africa
Actavis Plc., Boehringer Ingelheim, Endo Pharmaceuticals Inc., Egalet, Janssen Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Pfizer Inc., Purdue Pharma, Sanofi, Sun Pharmaceutical Industries Ltd. are few of the major manufacturers of global opioid drugs market. This research report contains detailed profiling of these players along with brief description and financial information.
Based on the wide application range of opioid drugs, this market is categorized as below:
- Pain Management
- Cough Suppressant
- Diarrhea
- Anesthesia
Pain management is estimated to be the spearheading segment as a result of effective outcomes of opioid drugs. Opioid drugs play an important role in treating acute or chronic pain. The World Health Organization stated that, 80% of cancer or AIDS patients and around 67% of patients suffering from pulmonary disease and cardiovascular diseases need medical intervention for relieving pain and this high trend drives the opioid drugs market. The opioid codeine is used as ‘gold standard’ for cough suppression. However, strict FDA regulation on the usage of opioid drugs in pediatric patients has negative impact on the global opioid drugs market. Opioid drugs are effective for treating chronic diarrhea by lengthening time to pass stool from gut, moreover severe side effects of opioid drug in inducing constipation might hinder the demand for opioid drugs. Opioid drugs are largely used as an anesthetic agent especially in cardiovascular surgical procedures and with increasing number of surgical interventions, the market of opioid drugs is expected to witness major growth.
Based on the drug types, the global market of opioid drugs has been classified as below:
- Morphine
- Methadone
- Codeine
- Oxycodone
- Meperidine
- Fentanyl
- Other Opioid Drugs
Most commonly used opioid drugs are morphine followed by codeine, which contribute major revenue to the global opioid drugs market. Morphine is enormously used in pain management for treating moderate to severe pain. Rising prevalence of cancer, arthritis, chronic pain and increasing recreational use of morphine are largely driving the global market of opioid drugs; however, the side effects and risks associated with this drug may affect the growth of opioid drugs market. Surging demand for codeine in pain relief and cough suppression fuel the growth of opioid drugs market; nonetheless, strict action against illegal practice of over-the-counter codeine drugs is expected to impact global opioid drugs market over the coming years. Methadone is gaining popularity due to its effective treatment of opioid-addiction by reducing withdrawal symptoms and diminishing cravings thus supporting the market growth. Fentanyl is more potent in terms of treatment of severe pain; the demand of this drug in treating surgical pain and increasing addiction to this drug have driven the global sales of opioids drugs.
Geographically, the global opioid drugs market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
North America region is predicted to experience the largest growth due to continuous increasing demand for opioid drugs followed by Europe. The National Institutes of Health has reported that in the year 2015 around 50 million Americans were suffering from severe chronic pain. Such high prevalence of acute and chronic pain acts as the major driver of opioid drugs market in North America. According to the American Society of Interventional Pain Physicians (ASIPP), 80% of global opioid drugs are being consumed in the United States; such high consumption rate and the overall increment in retail sales the since last two decades have driven the opioid drugs market in this region. Increasing illicit usage of opioid drugs like heroine fuels the growth of opioid drugs market in terms of commercial aspect. As per the recorded data in the Centers for Disease Control and Prevention (CDC), around 28,000 deaths were caused in 2014 due to opioid overdose in the United States. To fight against this epidemic, several initiatives have been taken by government to prevent opioid overdose and dependence which is expected to affect the overall growth of opioid drugs market. Europe is expected to experience steady growth as a result of lower non-medical usage of opioids than United States, and strict vigilance of opioid abuse.
Furthermore, rapid development in healthcare expenditure and attention to palliative care for therapy is expected to promote the growth of opioid drugs market in Asia Pacific. Booming market of opioids in China is owing to increasing rate of cancer cases and rising surgical interventions.
The report contains detailed geographical segmentation as below:
- North America (The United States & Canada)
- Europe (The United Kingdom, Germany & Rest of Europe)
- Asia Pacific (China, Japan, India & Rest of APAC)
- Latin America (Brazil, Mexico, & Rest of Latin America)
- Middle East and Africa (GCC & Rest of Middle East and Africa)
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Opioid Drugs Market Portraiture
2.1.1. Global Opioid Drugs Market, by Drug Type, 2016 (US$ Mn)
2.1.2. Global Opioid Drugs Market, by Application, 2016 (US$ Mn)
2.1.3. Global Opioid Drugs Market, by Geography, 2016 Vs. 2025 (Value %)
Chapter 3. Opioid Drugs Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Opioid Drugs: Future Trends
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2016
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2016
Chapter 4. Global Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Opioid Drugs Market, by Drug Type, 2016
4.2. Morphine
4.3. Methadone
4.4. Codeine
4.5. Oxycodone
4.6. Meperidine
4.7. Fentanyl
4.8. Others
Chapter 5. Global Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Opioid Drugs Market, by Application, 2016
5.2. Pain Management
5.3. Cough Suppressant
5.4. Diarrhea
5.5. Anesthesia
Chapter 6. Global Erectile Dysfunction Treatment Drugs Market: Pipeline Analysis
6.1. Overview
6.2. Phase III (Market estimations by 2025)
6.2.1. NKTR 181 (Nektar Therapeutics)
6.3. Phase II (Qualitative Information)
6.4. Phase I (Qualitative Information)
6.5. Preclinical Studies (Quantitative Information)
Chapter 7. Global Opioid Drugs Market, by Geography, 2015 – 2025 (US$ Mn)
7.1. Overview
7.2. North America Opioid Drugs Market Analysis, 2015 – 2025
7.2.1. North America Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
7.2.2. North America Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
7.2.3. North America Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
7.2.3.1. U.S.
7.2.3.2. Canada
7.3. Europe Opioid Drugs Market Analysis, 2015 – 2025
7.3.1. Europe Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
7.3.2. Europe Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
7.3.3. Europe Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
7.3.3.1. U.K.
7.3.3.2. Germany
7.3.3.3. Rest of Europe
7.4. Asia Pacific Opioid Drugs Market Analysis, 2015 – 2025
7.4.1. Asia Pacific Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
7.4.2. Asia Pacific Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
7.4.3. Asia Pacific Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
7.4.3.1. Japan
7.4.3.2. China
7.4.3.3. India
7.4.3.4. Rest of APAC
7.5. Latin America Opioid Drugs Market Analysis, 2015 – 2025
7.5.1. Latin America Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
7.5.2. Latin America Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
7.5.3. Latin America Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
7.5.3.1. Brazil
7.5.3.2. Mexico
7.5.3.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Opioid Drugs Market Analysis, 2015 – 2025
7.6.1. MEA Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
7.6.2. MEA Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
7.6.3. MEA Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
7.6.3.1. GCC
7.6.3.2. South Africa
7.6.3.3. Rest of MEA
Chapter 8. Company Profiles
8.1. Actavis Plc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Boehringer Ingelheim
8.3. Endo Pharmaceuticals Inc.
8.4. Egalet
8.5. Janssen Pharmaceuticals, Inc.
8.6. Mallinckrodt Pharmaceuticals
8.7. Pfizer Inc.
8.8. Purdue Pharma
8.9. Sanofi
8.10. Sun Pharmaceutical Industries Ltd.
TABLE 1 Global Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 3 Global Opioid Drugs Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 4 North America Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 5 North America Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 6 North America Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Asia Pacific Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 11 Asia Pacific Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn
TABLE 13 Latin America Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 14 Latin America Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 15 Latin America Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn
TABLE 16 Middle East and Africa Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 17 Middle East and Africa Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 18 Middle East and Africa Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 19 Actavis Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Boehringer Ingelheim: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Endo Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Egalet: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Janssen Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Mallinckrodt Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Purdue Pharma: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Sanofi: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Sun Pharmaceutical Industries Ltd: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
FIG. 1 Opioid Drugs: Market Segmentation
FIG. 2 Global Opioid Drugs Market Share, by Drug Type, 2016 (US$ Mn)
FIG. 3 Global Opioid Drugs Market Share, by Application, 2016 (US$ Mn)
FIG. 4 Global Opioid Drugs Market, by Geography, 2016 Vs. 2025 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography, 2016
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Morphine Market, 2015 – 2025 (US$ Mn)
FIG. 8 Global Methadone Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Codeine Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Oxycodone Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Meperidine Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Fentanyl Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Other Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Opioid Drugs Market for Pain Management, 2015 – 2025 (US$ Mn)
FIG. 15 Global Opioid Drugs Market for Cough Suppressant, 2015 – 2025 (US$ Mn)
FIG. 16 Global Opioid Drugs Market for Diarrhea, 2015 – 2025 (US$ Mn)
FIG. 17 Global Opioid Drugs Market for Anesthesia, 2015 – 2025 (US$ Mn)
FIG. 18 U.S. Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 19 Canada Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 20 U.K. Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 21 Germany Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 22 Rest Of Europe Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 23 Japan Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 24 China Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 25 India Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 26 Rest Of Asia Pacific Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 27 Brazil Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 28 Mexico Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 29 Rest Of Latin America Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 30 GCC Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 31 South Africa Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 32 Rest Of Middle East And Africa Opioid Drugs Market, 2015 – 2025 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)